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it does depend on endocytosis. Their 
findings show that HIV predominantly 
uses existing cellular endosomes as 
transport carriers to gain access to the 
cytoplasm. When fusion is induced at 
the plasma membrane, content mix-
ing is not observed. This block in virus 
entry at the plasma membrane can-
not be overcome by depolymeriza-
tion of the actin cytoskeleton. A better 
understanding of this block will likely 
explain why the virus has a preference 
for endocytosis. Given that HIV appears 
to use an endocytic pathway for entry, 
less well-studied viruses whose entry 
mechanisms are also pH independent 
deserve a second look.
Is this the end of the story on HIV 
entry? Certainly not. As technologies 
improve, the HIV entry pathway will 
likely be revisited. Super-resolution flu-
orescence microscopy will likely allow 
direct visualization of the proposed 
entry intermediates, such as lipid mix-
ing within endosomes. Future imaging 
technologies may also connect fusion 
and content mixing to downstream 
events such as uncoating, reverse tran-
scription, and nuclear import, thereby 
providing insights into the temporal and 
spatial coordination of HIV entry. Finally, 
HIV entry needs to be reanalyzed in the 
context of cell-to-cell transmission, its 
primary mode of spread. Recent prog-
ress in this area has captured HIV in the 
act of transmission and also points to a 
role for endocytosis in the target cell, but 
a detailed analysis of the entry mecha-
nism has not been performed (Hubner 
et al., 2009). The comprehensive study 
of Miyauchi et al. may be just one step in 
our journey to understand this virus that 
still kills millions of people each year. 
Although basic science may sometimes 
appear slow, the elegant experimental 
design applied by Miyauchi et al. pro-
vides insights that may facilitate the 
rational design of effective new thera-
pies to combat AIDS.
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Increasing evidence suggests that multiple metabolic pathways are regulated by sirtuin-dependent 
protein deacetylation in the mitochondria. In this issue, Nakagawa et al. (2009) show that the sirtuin 
SIRT5 deacetylates and activates a mitochondrial enzyme, carbamoyl phosphate synthetase 1, 
which mediates the first step in the urea cycle.Mitochondria are key players in metab-
olism, energy maintenance, and apop-
tosis. Disruption of mitochondrial path-
ways can lead to metabolic disease, 
oxidative damage, and cancer. There-
fore, elucidating how these pathways 
are regulated has therapeutic implica-
tions. There is compelling evidence that 
reversible acetylation of mitochondrial 
proteins is a key mechanism of meta-
bolic regulation. In this issue of Cell, 404 Cell 137, May 1, 2009 ©2009 Elsevier INakagawa et al. (2009) describe the 
regulation of the first step of the urea 
cycle by a previously uncharacterized 
mitochondrial sirtuin, SIRT5, through 
deacetylation of the mitochondrial 
enzyme carbamoyl phosphate syn-
thetase 1 (CPS1). A related study by 
Yu et al. (2009) describes the regulated 
acetylation of ornithine carbamoyltrans-
ferase (OTC), which catalyzes the sec-
ond step of the urea cycle. These studies nc.reveal that reversible protein acetylation 
is a major mechanism for regulating the 
urea cycle in mitochondria.
Conserved from bacteria to humans, 
sirtuins catalyze NAD+-dependent pro-
tein deacetylation. With some sirtuins, the 
ability to promote protein ADP-ribosyla-
tion has been reported (reviewed in Smith 
et al., 2008). In humans, there are seven 
sirtuins (SIRT1-SIRT7), three of which are 
localized to mitochondria (SIRT3, SIRT4, 
and SIRT5). SIRT3 deacetylates and 
activates mitochondrial acetyl-CoA syn-
thetase 2 (ACS2) (Hallows et al., 2006). 
ACS2 is regulated by reversible acetyla-
tion of lysine-635 (Figure 1). SIRT3 is a 
highly active mitochondrial deacetylase 
(Lombard et al., 2007) that deacetylates 
and activates complex I of the mitochon-
drial electron transport chain (Ahn et 
al., 2008) as well as isocitrate dehydro-
genase and glutamate dehydrogenase 
(GDH) (Schlicker et al., 2008). Meanwhile, 
SIRT4 inactivates GDH through ADP-
ribosylation (Haigis et al., 2006) (Figure 
1). The functional link between revers-
ible acetylation and ADP-ribosylation on 
GDH activity has not been determined. 
Previously, only cytochrome c was iden-
tified as a possible substrate for SIRT5 
deacetylation (Schlicker et al., 2008) (Fig-
ure 1), even though SIRT5 is localized to 
the mitochondrial matrix and cytochrome 
c is associated with the inner membrane 
facing the intermembrane space. A 
recent mass spectrometry study revealed 
the diversity of acetylated proteins (?130) 
that may exist within mitochondria (Kim et 
al., 2006), although there are likely to be 
many more.
In their new study, Nakagawa et al. 
(2009) identify CPS1 as the first in vivo 
substrate regulated by the NAD+-depen-
dent deacetylation activity of SIRT5. 
Using a polyclonal antibody to detect 
endogenous SIRT5 in mouse tissue, 
Nakagawa and coworkers first verified 
that SIRT5 is localized to the mitochon-
drial matrix, and then identified potential 
mitochondrial substrates using a SIRT5 
affinity column. Analysis of the column 
eluate by SDS-PAGE showed a band 
at ?150 kDa, which the authors identi-
fied as CPS1 by mass spectrometry. To 
confirm this interaction, CPS1 and SIRT5 
were coimmunoprecipitated from mouse 
liver samples. It is noteworthy that other 
unidentified protein bands were enriched 
from the SIRT5 affinity column. These 
may also represent SIRT5 substrates.
Next, Nakagawa et al. examined the 
activities of CPS1 and OTC. OTC cata-
lyzes the second step of the urea cycle, 
converting ornithine and carbamoyl 
phosphate to citrulline (Figure 1). Interest-
ingly, CPS1 activity in the liver mitochon-
dria of mice lacking SIRT5 (but not SIRT3 
or SIRT4) was ?30% lower than that of 
wild-type animals, though CPS1 lev-els remained unchanged. There was no 
apparent change in OTC activity in mice 
lacking SIRT3, SIRT4, or SIRT5 compared 
to wild-type mice. Furthermore, CPS1 
activity in cells from mice lacking SIRT5 
could be increased in vitro with recombi-
nant SIRT5, and this increase correlated 
with deacetylation of CPS1. However, the 
identity and stoichiometry of the lysines 
involved were not resolved. An important 
future experiment will be to determine 
how acetylation of specific lysines con-
trols CPS1 activity. For example, does 
stoichiometric acetylation of CPS1 on a 
particular lysine residue completely inac-
tivate CPS1, similar to the acetylation on/
off switch of ACS2 (Hallows et al., 2006)? 
Or does acetylation affect the conforma-
tion of CPS1 or interactions with other 
proteins or small-molecule regulators?
In a related study, Yu et al. (2009) 
describe the specific acetylation of OTC 
on lysine-88, a residue that is mutated in 
patients with OTC deficiency, an X-linked 
genetic disorder causing death of new-Ceborns or hyperammonemia in adults. 
Acetylation of OTC decreased its affinity 
for carbamoyl phosphate and the maxi-
mum rate of catalysis. Lysine-88 acetyla-
tion could be modulated by adding extra-
cellular glucose or amino acids. However, 
the protein acetyltransferase or the 
deacetylase responsible was not deter-
mined (Figure 1). Although the Nakagawa 
et al. study does not implicate SIRT3, 
SIRT4, or SIRT5 in the control of OTC 
activity, such a role might be revealed 
under different experimental conditions.
Because CPS1 catalyzes the first step 
of the urea cycle, Nakagawa et al. (2009) 
determined the physiological role of CPS1 
regulation in primary hepatocytes from 
mouse liver. Under starvation conditions, 
which increase urea production, mouse 
hepatocytes lacking SIRT5 displayed 
decreased viability compared to wild-type 
cells. Furthermore, after 48 hr of starva-
tion, CPS1 deacetylation and activation in 
liver mitochondria was increased in wild-
type but not SIRT5-deficient animals. To figure 1. Regulation of mitochondrial enzymes by sirtuins
In the mitochondrial matrix, SIRT3 deacetylates and activates acetyl CoA synthetase 2 (ACS2), lead-
ing to an increase in acetyl-CoA production from acetate. Deacetylation of glutamate dehydrogenase 
(GDH) increases formation of α-ketoglutarate, and deacetylation of complex I (electron transport chain) 
increases oxidative phosphorylation. SIRT4 ADP-ribosylates and inhibits GDH, which inhibits insulin 
secretion by pancreatic β cells. SIRT5 deacetylates and activates CPS1, increasing flux through the 
urea cycle. Citrulline biosynthesis is also regulated by OTC acetylation through an as yet uncharacter-
ized mechanism.ll 137, May 1, 2009 ©2009 Elsevier Inc. 405
directly correlate these results with the 
urea cycle, the authors measured a 2-fold 
increase in blood ammonia in SIRT5-defi-
cient compared to wild-type mice, indi-
cating disruption of the urea cycle.
Nakagawa et al. hypothesized that SIRT5 
might be activated under stress condi-
tions, such as fasting, through an increase 
in NAD+ concentration. In line with previous 
reports (Yang et al., 2007), they found that 
under fasting conditions, NAD+ concen-
trations doubled in the mitochondria and 
that cellular Nampt (an NAD+ biosynthetic 
enzyme) increased 2- to 3-fold. However, 
the authors did not observe a correspond-
ing increase in mitochondrial Nampt levels 
as previously observed in rats (Yang et al., 
2007), but mouse Nampt may not translo-
cate to mitochondria. Nakagawa et al. sug-
gest that increased cytoplasmic Nampt 
increases nicotinamide mononucleotide 
(NMN), which may traverse the membrane 
and move into the mitochondrial matrix, 
leading to increased NAD+. Further studies 
are needed to demonstrate that the kinetic 
properties of the three enzymes—Nampt, 
Nmnat, and SIRT5—would support this 
model.
During caloric restriction of wild-type 
mice, CPS1 activity increased although 
SIRT5 and CPS1 protein levels remained 406 Cell 137, May 1, 2009 ©2009 Elsevier Inunchanged (Nakagawa et al., 2009). 
There was a decrease in CPS1 acetyla-
tion and an ?50% increase in mitochon-
drial NAD+, suggesting that an increase 
in SIRT5 activity was responsible for the 
decrease in CPS1 acetylation and sub-
sequent enhanced CPS1 activity.
The Nakagawa et al. study bolsters 
emerging evidence that sirtuin-mediated 
reversible acetylation is a major regulator 
of mitochondrial proteins. Perhaps most 
astonishing, the new work of Nakagawa et 
al. and Yu et al. demonstrates that acetyla-
tion modulates the activity of three inex-
tricably linked metabolic enzymes: GDH, 
CPS1, and OTC (Figure 1). Many intriguing 
questions remain. How are these mito-
chondrial proteins acetylated? Are they 
acetylated in the cytoplasm before import 
into mitochondria, or are there as yet undis-
covered mitochondrial protein acetyltrans-
ferases? Also, elucidating the specificity of 
mitochondrial sirtuins for a growing list of 
acetylated protein substrates may reveal 
how the different sirtuins regulate diverse 
mitochondrial processes. Regulation of 
the urea cycle through reversible acety-
lation provides additional support for the 
emerging theme that reversible protein 
acetylation is a major mechanism for regu-
lating metabolic processes.c.RefeRences
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